Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
about
Glucose-insulin-potassium (GIK) and tight-glycaemic-control (TGC) versus standard therapy insulin for critically ill patientsGlucose-insulin-potassium (GIK) and tight-glycaemic-control (TGC) versus standard therapy insulin for critically ill patientsA review of the use of insulin protocols to maintain normoglycaemia in high dependency patients.Predictors of insulin resistance in pediatric burn injury survivors 24 to 36 months postburn.Disturbance of glucose homeostasis after pediatric cardiac surgeryDiagonal earlobe crease and coronary artery disease in a Chinese population.Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial.Puerarin alleviates burn-related procedural pain mediated by P2X(3) receptors.Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.Hypoglycemia and glycemic variability are associated with mortality in non-intensive care unit hospitalized infectious disease patients with diabetes mellitus.Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: a randomized, controlled study.Blood glucose control in critical care patients - a review of the literature.Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial.Glycemic control in non-diabetic critically ill patients.Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization.Insulin therapy for the management of hyperglycemia in hospitalized patientsAbnormal insulin sensitivity persists up to three years in pediatric patients post-burnHyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study.Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.The hepatic response to thermal injury: is the liver important for postburn outcomes?Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stressReducing glycemic variability in intensive care unit patients: a new therapeutic target?Glycemic control in critically ill patients.What, how, and how much should patients with burns be fed?The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia.Current state of glycemic control in critically ill subjects in a general intensive care unit.Effect of intercostal nerve block combined with general anesthesia on the stress response in patients undergoing minimally invasive mitral valve surgery.Burn injury: review of pathophysiology and therapeutic modalities in major burns.Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis.Incidence and clinical relevance of hyperglycemia in critically ill dogs.Glycemic control in acute illness.Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.Nurses' rationale for blood glucose monitoring in critical care.Novel events in the molecular regulation of muscle mass in critically ill patients.Etiology of hyperglycemia in critically ill children and the impact of organ dysfunctionMetabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients
P2860
Q24198934-DA575DCA-565F-489E-8BFE-259791CB6CDDQ24240512-C26CA933-6C07-4E8A-B451-9A47DD68330DQ33267162-505D12BC-2037-462D-A1E9-645C8F6E9E07Q34173618-1A045049-4785-4FA2-A50B-7CF130E0FD0DQ34551238-9DC84E0E-0696-484A-B25B-10C6F64E3B32Q35141204-426C654B-ECDC-47ED-92A3-52F0AFC6D266Q35347811-EE4B993B-A252-4FCE-8F7E-6B819E13A7F6Q35574509-33271C3C-3F47-4E83-8B39-AC091923D9F8Q36183957-A3E455F2-F2BF-43D4-B77E-24A8D410867DQ36843938-7ABE12CC-0F20-4332-BBF6-E5E6DB3808BCQ36925816-E5B69C6A-CB6A-4FBB-9DB0-DD2F54346D1AQ36947210-B802279C-7A5D-4A0B-BC34-0268A6919F72Q36993140-4A54E7A4-714A-4648-8EC6-0F7D4A217CEAQ37032717-55BCD9E0-9570-43DC-916D-AC10969734F7Q37078679-7A5F1A40-5FBB-4F8B-8A02-0B0A52EAB881Q37082032-9C7D5E99-4329-4ECF-BD8C-DD4030F2A4A8Q37198029-B137E0FC-80C5-46DC-BD0A-95CDF5B66B6FQ37206795-46FE0489-8AA1-44B4-86B8-14747AF2FEFBQ37241722-F58C26E0-08F6-4FB5-BF5C-D6D8611B274DQ37260905-6E564266-6742-49BC-885C-15765034E16EQ37422501-0E6E6408-3FB8-4FC7-837D-EAE27AD7D66EQ37453086-ED14B1AC-7D21-4A78-A479-4215344741C3Q37640683-274DAD81-553A-469B-BF05-410DED394BE6Q37881472-6E0F45DB-C3F2-40A8-B016-4D97BF2B4CC5Q38771951-393D1EAA-ABD7-43C7-A4BE-842DB20E7290Q39980377-3FBC4402-FFFF-4A0D-8C57-ADE59413EEA3Q40305828-8C1D2271-2E1D-4C5F-BA34-A2037BBB9D1EQ40425736-4CF05097-597D-4FFB-975A-E2639A9D7DBCQ41623752-49FAAFAC-5E1A-479B-B484-59CC22CEB058Q41923931-2D9A5B0F-2E7B-4721-9212-111560CF8576Q46766187-9D4DCB2F-D437-4035-A5C7-A07834169BBCQ46948313-9DE8DD0B-F026-43B9-B72D-6985D8FED4A1Q47154512-8306A137-5A5E-47B5-A617-367352BC124CQ48254513-396262EF-7D13-4A85-B6AF-95DD78B6FAFAQ48396316-546859FB-CF97-47E9-9041-F351C7E8DDB9Q54582240-9D99B4BD-A44E-4581-84A7-2DF597353940Q57496608-31EAFE5E-3FC0-44D6-AD65-7397645A12ABQ57834176-B75427CF-7C09-4B70-AFD9-F3CC8AB5D50A
P2860
Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Insulin resistance and hypergl ...... f insulin in glycemic control.
@ast
Insulin resistance and hypergl ...... f insulin in glycemic control.
@en
type
label
Insulin resistance and hypergl ...... f insulin in glycemic control.
@ast
Insulin resistance and hypergl ...... f insulin in glycemic control.
@en
prefLabel
Insulin resistance and hypergl ...... f insulin in glycemic control.
@ast
Insulin resistance and hypergl ...... f insulin in glycemic control.
@en
P1476
Insulin resistance and hypergl ...... f insulin in glycemic control.
@en
P2093
Lindsay E Robinson
Mary H van Soeren
P356
10.1097/00044067-200401000-00004
P407
P577
2004-01-01T00:00:00Z